Search results for "Amyotrophic lateral sclerosis"

showing 10 items of 228 documents

Sleep–wake problems in patients with amyotrophic lateral sclerosis: implications for patient management

2012

SUMMARY Sleep–wake problems are frequent, although unrecognized, complications of amyotrophic lateral sclerosis (ALS). Sleep disorders such as insomnia, sleep-disordered breathing and restless legs syndrome have all been reported in patients with ALS, despite the limited number of studies and the small populations investigated so far. Sleep disturbances gradually worsen with disease progression, suggesting a relationship between the severity of disease and the neurodegenerative process. However, poor sleep can also be a consequence of several disturbances such as anxiety, depression, pain, choking, sialorrhea, fasciculations, cramps, nocturia and the inability to get comfortable and move f…

medicine.medical_specialtybusiness.industrymedicine.diseasePhysical medicine and rehabilitationExcessive daytime somnolencemedicineInsomniaNocturiaAnxietyNeurology (clinical)Restless legs syndromemedicine.symptomAmyotrophic lateral sclerosisChokingbusinessDepression (differential diagnoses)Neurodegenerative Disease Management
researchProduct

Tumors preceding ALS onset and ALS: results from a case-control study.

2009

Amyotrophic Lateral Sclerosis Cancer Case-comntrol studySettore MED/26 - Neurologia
researchProduct

A Human-Humanoid Interaction Through the Use of BCI for Locked-In ALS Patients Using Neuro-Biological Feedback Fusion.

2018

This paper illustrates a new architecture for a human–humanoid interaction based on EEG-brain computer interface (EEG-BCI) for patients affected by locked-in syndrome caused by Amyotrophic Lateral Sclerosis (ALS). The proposed architecture is able to recognise users’ mental state accordingly to the biofeedback factor $\text {B}_{\text f}$ , based on users’ attention, intention, and focus, that is used to elicit a robot to perform customised behaviours. Experiments have been conducted with a population of eight subjects: four ALS patients in a near locked-in status with normal ocular movement and four healthy control subjects enrolled for age, education, and computer expertise. The results s…

MaleEye MovementsBCI Locked-In Patients ALS Patients Human-Humanoid Robot Interaction neuro-biological feedback fusionmedicine.medical_treatment02 engineering and technology0302 clinical medicineAttentionBCIAmyotrophic lateral sclerosiseducation.field_of_studyGeneral NeuroscienceRehabilitationlocked-in patientsRoboticsElectroencephalographyRoboticsHealthy VolunteersBrain-Computer InterfacesFemalePsychologyHumanoid robotAlgorithmsAdultmedicine.medical_specialty0206 medical engineeringPopulationhuman-humanoid robot interactionBiomedical EngineeringBiofeedbackProsthesis DesignQuadriplegia03 medical and health sciencesPhysical medicine and rehabilitationEvent-related potentialInternal MedicinemedicineHumanseducationBrain–computer interfacebusiness.industryAmyotrophic Lateral SclerosisEye movementBiofeedback Psychologymedicine.disease020601 biomedical engineeringEvent-Related Potentials P300neuro-biological feedback fusionALS patientsArtificial intelligencebusiness030217 neurology & neurosurgeryPsychomotor PerformanceIEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society
researchProduct

A Deletion of the Nuclear Localization Signal Domain in the Fus Protein Induces Stable Post-stress Cytoplasmic Inclusions in SH-SY5Y Cells

2021

Mutations in Fused-in-Sarcoma (FUS) gene involving the nuclear localization signal (NLS) domain lead to juvenile-onset Amyotrophic Lateral Sclerosis (ALS). The mutant protein mislocalizes to the cytoplasm, incorporating it into Stress Granules (SG). Whether SGs are the first step to the formation of stable FUS-containing aggregates is still unclear. In this work, we used acute and chronic stress paradigms to study the SG dynamics in a human SH-SY5Y neuroblastoma cell line carrying a deletion of the NLS domain of the FUS protein (homozygous: ΔNLS–/–; heterozygous: ΔNLS+/–). Wild-type (WT) cells served as controls. We evaluated the subcellular localization of the mutant protein through immuno…

amyotrophic lateral sclerosisstomatognathic systemGeneral Neurosciencecytoplasmic inclusionsNeurosciences. Biological psychiatry. NeuropsychiatrySettore MED/26 - Neurologianuclear localization signal (NLS)stress granules (SG)Fused-in-Sarcoma proteinRC321-571NeuroscienceOriginal Research
researchProduct

Poor Bone Quality in Patients With Amyotrophic Lateral Sclerosis

2020

Objective: Musculoskeletal functional deterioration in Amyotrophic lateral sclerosis (ALS) is associated with an increase in bone fractures. The purpose of this study was to evaluate the influence of sex, ALS type, on bone quality in patients with ALS compared to healthy controls. The impact on bone health of the clinical status and some metabolic parameters was also analyzed in ALS patients.Methods: A series of 33 voluntary patients with ALS, and 66 healthy individuals matched in sex and age underwent assessment of bone mass quality using quantitative ultrasound (QUS) of the calcaneus. Ultrasonic broadband attenuation (BUA), the speed of sound (SOS), stiffness index and T-score were measur…

medicine.medical_specialtyamyotrophic lateral sclerosisOsteoporosisvitamin DPhysical strengthGastroenterologylcsh:RC346-429Pulmonary function testingFEV1/FVC ratioInternal medicinemedicineVitamin D and neurologyAmyotrophic lateral sclerosisamyotrophic lateral sclerosis bone quality neurodegeneration osteoporosis quantitative ultrasound (QUS) measurement vitamin DOssos Malaltieslcsh:Neurology. Diseases of the nervous systemBone mineralquantitative ultrasound (QUS) measurementbusiness.industryneurodegenerationBrief Research Reportmedicine.diseaseosteoporosisbone qualityNeurologyCalcaneusNeurology (clinical)business
researchProduct

Two in one against motor neuron degeneration: tackling oxidative stress and inflammation with a sulfasalazine derivative.

2012

Free RadicalsInflammationPharmacologymedicine.disease_causeBiochemistryDinoprostoneCellular and Molecular Neurosciencechemistry.chemical_compoundSulfasalazinemedicineAnimalsHumansAmyotrophic lateral sclerosisbusiness.industryAmyotrophic Lateral SclerosisAnti-Inflammatory Agents Non-Steroidalmedicine.diseaseDinoprostoneSulfasalazinechemistryAnesthesiaMotor neuron degenerationmedicine.symptombusinessOxidative stressDerivative (chemistry)medicine.drugJournal of neurochemistry
researchProduct

Hypothesis: Etiologic and Molecular Mechanistic Leads for Sporadic Neurodegenerative Diseases Based on Experience With Western Pacific ALS/PDC

2019

Seventy years of research on Western Pacific amyotrophic lateral sclerosis and Parkinsonism-dementia Complex (ALS/PDC) have provided invaluable data on the etiology, molecular pathogenesis and latency of this disappearing, largely environmental neurodegenerative disease. ALS/PDC is linked to genotoxic chemicals (notably methylazoxymethanol, MAM) derived from seed of the cycad plant (Cycas spp.) that were used as a traditional food and/or medicine in all three disease-affected Western Pacific populations. MAM, nitrosamines and hydrazines generate methyl free radicals that damage DNA (in the form of O6-methylguanine lesions) that can induce mutations in cycling cells and degenerative changes …

0301 basic medicineamyotrophic lateral sclerosisDNA damageDiseaseBiologylcsh:RC346-429Environmental - originProgressive supranuclear palsy03 medical and health sciences0302 clinical medicineHypothesis and TheorymedicinenitrosaminesAmyotrophic lateral sclerosislcsh:Neurology. Diseases of the nervous systemhydrazinesprogressive supranuclear palsymedicine.diseaseatypical parkinsonism030104 developmental biologyBrain degenerationNeurologyImmunologyEtiologycycad methylazoxymethanol and L-BMAADNA damageNeurology (clinical)Alzheimer's diseaseAlzheimer disease030217 neurology & neurosurgeryFrontiers in Neurology
researchProduct

Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials?

2016

Intraspinal stem cell (SC) transplantation represents a new therapeutic approach for amyotrophic lateral sclerosis (ALS) clinical trials. There are considerable difficulties in designing future efficacy trials, some related to the field of ALS and some that are specific to SCs or the mode of delivery. In October 2015, the most controversial points on SC transplantation were addressed during an international workshop intended to bring together international SC and ALS researchers in a public discussion on a topic for which expertise is limited. During the meeting, a discussion was started on the basic structure of the ideal clinical trial testing the efficacy and safety of SC transplantation…

0301 basic medicineCancer ResearchCell- and Tissue-Based Therapy0302 clinical medicinePublic discussionNeural Stem CellsImmunology and AllergyNeural Stem CellALS; clinical trials; stem cells; transplantation; Immunology and Allergy; Immunology; Oncology; Genetics (clinical); Cell Biology; Cancer Research; TransplantationAmyotrophic lateral sclerosisGenetics (clinical)clinical trialMiddle AgedOncologyStem cellSafetyHumanAdultmedicine.medical_specialtyConsensusAdolescentImmunologyConsensu03 medical and health sciencesTherapeutic approachYoung AdultClinical Trials Phase II as Topicstem cellsmedicineHumansIntensive care medicineAgedclinical trialsTransplantationbusiness.industryAmyotrophic Lateral SclerosisBIO/13 - BIOLOGIA APPLICATACell Biologymedicine.diseasestem cellClinical trialTransplantation030104 developmental biologyClinical Trials Phase III as TopicImmunologyALSbusiness030217 neurology & neurosurgeryAmyotrophic Lateral SclerosiStem Cell TransplantationCytotherapy
researchProduct

THORACIC SYRINGOMYELIA IN A PATIENT WITH AMYOTROPHIC LATERAL SCLEROSIS

2015

We report a patient with bulba r - onset, clinically defined, sporadic amyotrophic lateral sclerosis bearing an isolated syringomyelia of the lower thoracic portion of the spinal cord. This is a very unusual association between two rare and progressive disorders, both affecting the spinal motoneurons. Syringomyelia might have acted as a phenotypic modifier in this ALS patient.

Community and Home Caremedicine.medical_specialtybusiness.industrymedicine.diseasePhenotypic modifierSpinal cordSurgerymedicine.anatomical_structureALS syringomyelia case reportmedicineSettore MED/26 - NeurologiaAmyotrophic lateral sclerosisbusinessSyringomyelia
researchProduct

DIGITAL CINERADIOGRAPHIC STUDY OF SWALLOWING IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS

2007

Purpose. This study was performed to evaluate the usefulness of digital cineradiography in detecting swallowing disorders in dysphagic patients affected by amyotrophic lateral sclerosis (ALS) with a view to planning an adequate therapeutic approach. Material and methods. From January 2005 to September 2006, 23 patients (10 men and 13 women; mean age 41.3±8.6 years) affected by ALS were evaluated with digital cineradiography to assess the grade of dysphagia. All patients were classified using the Hillel ALS Severity Scale (ALSSS). All examinations were performed with radiocontrolled equipment provided with a digital C-arm. Results. The cineradiographic technique enabled us to differentiate p…

AdultMalemedicine.medical_specialtyTherapeutic approachPhysical medicine and rehabilitationSwallowingMedicineHumansRadiology Nuclear Medicine and imagingAmyotrophic lateral sclerosisNeuroradiologymedicine.diagnostic_testbusiness.industrySwallowing DisordersCineradiographyAmyotrophic Lateral SclerosisInterventional radiologyGeneral MedicineMiddle Agedmedicine.diseaseDysphagiaPhysical therapyFemaleSwallowing Dysphagia Amyotrophic lateral sclerosis Cineradiographymedicine.symptombusinessDeglutition DisordersCineradiography
researchProduct